ClinicalTrials.govpublic full text
Efficacy and Safety of Grass Pollen Sublingual Immunotherapy
allergic rhinoconjunctivitis, randomised, double-blind, placebo-controlled, efficacy and safety, oralgen® grass pollen, allergy, rhinoconjunctivitis, immunotherapy, grass pollen extract, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 886385
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.